[Smoking in COPD].
Smoking is a recurrent, chronic addictive disease that causes multiple diseases and is the main known cause of avoidable morbidity and mortality, constituting a major public health problem. In developed countries, smoking is the main single cause of premature preventable morbidity and mortality. Tobacco combustion releases more than 4,000 toxic substances and more than 50 substances with demonstrated carcinogenic effects; smoking is a risk factor for six of the eight main causes of death worldwide. The treatment of smoking is both effective and cost-effective. Any therapeutic intervention performed by health professions for smoking will have beneficial results. If such interventions are adapted to the individual characteristics of each patient, their efficacy and efficiency will be much greater. All treatments are safe, with generally mild adverse effects that rarely lead to treatment withdrawal. Patients with COPD show higher nicotine dependence and seem to have greater difficulty in quitting smoking. Nevertheless, smoking cessation should be a priority in these patients, as it constitutes the only measure able to halt progression of the disease.
Servicio de Neumología, Hospital Ramón y Cajal, Madrid, España.
Celia
C
Zamarro García
M José
MJ
Bernabé Barrios
Beatriz
B
Santamaría Rodríguez
Juan Luis
JL
Rodríguez Hermosa
D001552:Benzazepines / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D015897:Comorbidity; D018450:Disease Progression; D005060:Europe / Q000453:epidemiology; D006801:Humans; D009042:Motivation; D018722:Nicotinic Agonists / Q000627:therapeutic use; D009661:Nortriptyline / Q000627:therapeutic use; D015995:Prevalence; D029424:Pulmonary Disease, Chronic Obstructive / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D011810:Quinoxalines / Q000627:therapeutic use; D012720:Severity of Illness Index; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology* / Q000523:psychology; D016540:Smoking Cessation; D013375:Substance Withdrawal Syndrome / Q000209:etiology / Q000517:prevention & control; D014029:Tobacco Use Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D000068580:Varenicline
D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D016642:Bupropion; D009661:Nortriptyline; D003000:Clonidine; D000068580:Varenicline